Tsumura & Co.:企業の戦略・SWOT・財務情報

◆英語タイトル:Tsumura & Co. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1947
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Tsumura & Co. – Strategy, SWOT and Corporate Finance Report
Summary

Tsumura & Co. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Tsumura & Co. (Tsumura or ‘the company’) is engaged in the manufacturing and sale of pharmaceutical products, including primarily prescription Kampo products. The company operates in Japan, China, South Korea and other countries. It is headquartered in Tokyo, Japan and employed 3,242 people as of March 31, 2016.

Scope

- Detailed information on Tsumura & Co. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Tsumura & Co. in the form of a SWOT analysis
- An in-depth view of the business model of Tsumura & Co. including a breakdown and examination of key business segments
- Intelligence on Tsumura & Co.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Tsumura & Co., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Tsumura & Co. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Tsumura & Co. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Tsumura & Co.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Tsumura & Co.: Company Overview 8
Tsumura & Co.: Overview and Key Facts 8
Tsumura & Co.: Overview 8
Tsumura & Co.: Key Facts 8
Tsumura & Co.: Key Employees 9
Tsumura & Co.: Key Employee Biographies 10
Tsumura & Co.: Major Products and Services 12
Tsumura & Co.: Company History 13
Tsumura & Co.: Management Statement 15
Tsumura & Co.: Locations and Subsidiaries 16
Tsumura & Co.: Key Competitors 17
Tsumura & Co.: Company Analysis 18
Tsumura & Co.: Business Description 18
Tsumura & Co.: SWOT Analysis 19
Tsumura & Co.: SWOT Overview 19
Tsumura & Co.: Strengths 19
Tsumura & Co.: Weaknesses 20
Tsumura & Co.: Opportunities 20
Tsumura & Co.: Threats 22
Tsumura & Co.: Corporate Financial Deals Activity 23
Tsumura & Co.: Financial Deals Overview 23
Tsumura & Co.: Targets and Partners 25
Tsumura & Co.: Top Deals 2014 – 2018YTD* 26
Tsumura & Co.: Advisors 27
Tsumura & Co.: Top Financial Advisors 27
Tsumura & Co.: Capital Raising 28
Tsumura & Co.: Partnership 29
Appendix 30
Contact Us 30
Methodology 30
About MarketLine 31

List of Tables
Table 1: Tsumura & Co.: Key Facts
Table 2: Tsumura & Co.: Key Employees
Table 3: Tsumura & Co.: Locations and Subsidiaries
Table 4: Tsumura & Co.: Key Competitors
Table 5: Tsumura & Co.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Tsumura & Co.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Tsumura & Co.: Targets and Partners
Table 8: Tsumura & Co.: Top Deals 2014 - 2018YTD*
Table 9: Tsumura & Co.: Financial Advisor Ranking by Value (US$m)
Table 10: Tsumura & Co.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: Tsumura & Co.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: Tsumura & Co.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Tsumura & Co.: Partnership Trend by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: Tsumura & Co.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Tsumura & Co.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Tsumura & Co.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: Tsumura & Co.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: Tsumura & Co.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Tsumura & Co.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Tsumura & Co.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boston Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AeroMaoz Ltd.:企業の戦略・SWOT・財務情報
    AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report Summary AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • EuroSibEnergo Plc:企業の戦略的SWOT分析
    EuroSibEnergo Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Mylan N.V.:企業の戦略・SWOT・財務情報
    Mylan N.V. - Strategy, SWOT and Corporate Finance Report Summary Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Red Electrica de Espana SA (REE)-エネルギー分野:企業M&A・提携分析
    Summary Red Electrica de Espana, S.A. (REE), a subsidiary of Red Electrica Corporacion S A. is a power transmission company. The company is involved in electricity transmission and other related operations through its transmission network. It manages the high-voltage transmission grid and is also re …
  • Hikma Pharmaceuticals PLC:企業の戦略・SWOT・財務分析
    Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report Summary Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Gordon Ramsay Holdings Limited:企業の戦略・SWOT・財務情報
    Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NaiKun Wind Energy Group Inc (NKW):企業の財務・戦略的SWOT分析
    Summary NaiKun Wind Energy Group Inc (NaiKun Wind Energy) is a renewable energy company that develops offshore wind energy projects to generate electricity. The company’s engineering services include installation of a meteorological station to collect wave, wind, and climate information and completi …
  • Vivus Inc (VVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's marketed products include, Qsymia (phentermine and topiramate extended-release), indic …
  • Svenska Handelsbanken AB:企業のM&A・事業提携・投資動向
    Svenska Handelsbanken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Handelsbanken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Glomac Berhad:企業の戦略・SWOT・財務情報
    Glomac Berhad - Strategy, SWOT and Corporate Finance Report Summary Glomac Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Samart Corporation Public Co Ltd (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Public Co Ltd (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Victoria PLC (VCP):企業の財務・戦略的SWOT分析
    Victoria PLC (VCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) is a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purification, a …
  • ePlus Inc (PLUS):企業の財務・戦略的SWOT分析
    ePlus Inc (PLUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sequella Inc-医療機器分野:企業M&A・提携分析
    Summary Sequella Inc (Sequella) is a clinical-stage pharmaceutical company that develops and commercializes small molecule and natural product-based therapeutics for the treatment of infectious diseases. The company’s product pipeline include SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid anti …
  • Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company's products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research …
  • Jamba, Inc.:企業の戦略・SWOT・財務分析
    Jamba, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jamba, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆